Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Journal of Clinical Oncology | Mar 22, 2019 Clinical Pharmacology

Comparison of narrowband UV-B with psoralen–UV-A phototherapy for patients with early-stage mycosis fungoides: A systematic review and meta-analysis

JAMA | Mar 20, 2019 Clinical Pharmacology

Trends in oral antibiotic prescription in dermatology, 2008 to 2016

JAMA | Mar 20, 2019 Clinical Pharmacology

Evaluation of the response of unresectable primary cutaneous melanoma to immunotherapy visualized with reflectance confocal microscopy: A report of 2 cases

JAMA | Mar 20, 2019 Clinical Pharmacology

Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation

JAMA | Mar 18, 2019 Clinical Pharmacology

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: Pooled analysis of 3 randomized controlled trials at weeks 12 and 28

Journal of the European Academy of Dermatology and Venereology | Mar 10, 2019 Clinical Pharmacology

Primary melanoma histologic subtype: Impact on survival and response to therapy

Journal of the National Cancer Institute | Mar 08, 2019 Clinical Pharmacology

¹⁸F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma

The Journal of Nuclear Medicine | Mar 08, 2019 Clinical Pharmacology

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): A multicentre, open-label, randomised, controlled phase II trial

Annals of Oncology | Mar 07, 2019 Clinical Pharmacology

Safety of metformin in psoriasis patients with diabetes mellitus: A 17-year population-based real-world cohort study

Journal of Clinical Endocrinology and Metabolism | Mar 06, 2019 Clinical Pharmacology

« Prev 1 … 58 59 60 61 62 … 92 Next »

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Comparison of narrowband UV-B with psoralen–UV-A phototherapy for patients with early-stage mycosis fungoides: A systematic review and meta-analysis

Trends in oral antibiotic prescription in dermatology, 2008 to 2016

Evaluation of the response of unresectable primary cutaneous melanoma to immunotherapy visualized with reflectance confocal microscopy: A report of 2 cases

Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: Pooled analysis of 3 randomized controlled trials at weeks 12 and 28

Primary melanoma histologic subtype: Impact on survival and response to therapy

¹⁸F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): A multicentre, open-label, randomised, controlled phase II trial

Safety of metformin in psoriasis patients with diabetes mellitus: A 17-year population-based real-world cohort study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Comparison of narrowband UV-B with psoralen–UV-A phototherapy for patients with early-stage mycosis fungoides: A systematic review and meta-analysis

Trends in oral antibiotic prescription in dermatology, 2008 to 2016

Evaluation of the response of unresectable primary cutaneous melanoma to immunotherapy visualized with reflectance confocal microscopy: A report of 2 cases

Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation

Efficacy of tildrakizumab for moderate-to-severe plaque psoriasis: Pooled analysis of 3 randomized controlled trials at weeks 12 and 28

Primary melanoma histologic subtype: Impact on survival and response to therapy

18F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): A multicentre, open-label, randomised, controlled phase II trial

Safety of metformin in psoriasis patients with diabetes mellitus: A 17-year population-based real-world cohort study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic

¹⁸F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma